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tween 1 August 1992 and the date of RTA. For each
driver, the probability of having the RTA while exposed to
a drug was compared with the probability while unex-
posed.
RESULTS: Of 19,386 drivers with a first RTA during the
study period, 1,731 were users of any study drug. On the
days of the accidents, 189 subjects were taking TCAs, 84
were taking selective SSRI, 235 were taking benzodiaz-
epines, and 47 were taking other psychoactive drugs. The
treatment-group exposure relative risks were 0.93 (95%
confidence interval [CI] 0.72–1.21) for TCAs, 0.85
(0.55–1.33) for SSRIs, 1.62 (1.24–2.12) for benzodiaz-
epines, and 0.88 (0.62–1.225) for other psychotropics.
The benzodiazepine risk decreased with increasing driver
age and increased in subjects with positive breath tests for
alcohol. A dose-response relationship was evident with
benzodiazepines, the relative risk increasing with dose.
CONCLUSION: Users of benzodiazepines were at in-
creased risks of experiencing a road traffic accident; how-
ever, users of TCAs and SSRIs were not. Users of benzo-
diazepines should not drive.
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OBJECTIVE: There are limited data linking benzodiaz-
epine prescribing to road traffic accidents (RTA) and hip
fractures but “epidemiological evidence for increased
risks of several kinds of accidents with benzodiazepine
use remains inconclusive.”
METHODS: We used a case control study. Between June
1993 and October 1995, 4019 people were admitted
with fractures and 3186 people were admitted with
trauma other than fracture from a fixed Tayside popula-
tion of 319,465. Of the population as a whole, 19,304
people were dispensed benzodiazepines between June
1993 and October 1995 but had not been exposed in the
previous 6 months.
RESULTS: Benzodiazepine users had an increased risk of
admission for fractures (odds ratio [OR] 1.9; 95% CI
1.7–2.1) and other trauma (OR 1.6; CI 1.4–1.8). The risk
of fracture was markedly age-related. The numbers needed
to treat (NNT) for one associated admission with frac-
ture was 95 (CI 79–120) for the whole population, but
the NNT fell from 199 (CI 111–918) at age 30–39 to 9
(CI 6–17) at age 90–99. The risk of other trauma was
also age-related but showed a bimodal distribution. The
NNT for one admission with other trauma were 163 (CI
126–234) for the whole population. At age 20–29 the
NNT was 72 (CI 47–154), rising to 376 at age 40–49 and
falling again to 61 (CI 38–167) at age 80–89.
CONCLUSION: These results challenge the widely held
belief that benzodiazepine drugs are safe with few serious
side effects.
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OBJECTIVE: Because antidepressants are prescribed for
numerous conditions, users of administrative databases
for conducting research on depression must be cautious.
We examined the Saskatchewan Health databases, con-
taining three-digit ICD-9 codes, concurrent medications,
prescriber information, comorbidities, and fee-for-service
codes, to determine their suitability for conducting depres-
sion research. 
METHODS: We identified a cohort of individuals who
began a “new” period of antidepressant use (no use 180
days prior) with at least one additional dispensation of
the antidepressant. A stratified random sample of 600 in-
dividuals was chosen for medical record abstraction. The
medical record abstraction classification of depression
was the gold standard against which our definitions of
depression were judged. We developed a primary defini-
tion of depression based on ICD-9 codes and tried to fur-
ther refine it with various algorithms. Since so few pa-
tients were false-positive and/or false-negative in the
primary classification, it was not feasible to split the data
and use pattern recognition techniques. Instead, we devel-
oped medically probable scenarios using the explanatory
variables and evaluated them for their sensitivity, speci-
ficity, and predictive values.
RESULTS: Defining depression using the ICD-9 codes
296 (affective disorders), 309 (adjustment reaction), and
311 (depressive disorders) had a sensitivity of 71%, a
specificity of 85%, a positive predictive value (PV
) of
86%, and a negative predictive value (PV	) of 70%. Us-
ing other definitions gave different results: limiting the
number of false-negatives raised the sensitivity to 84%
and the PV	 to 77%; limiting false-positives raised the
specificity 90% and PV
 to 86%. The false-negatives
had very similar characteristics to the true-positives.
CONCLUSION: The ICD-9 definition will permit future
studies of depression to be conducted using the Saskatch-
ewan Health databases.
